WHO Halts HCQ Trials For COVID-19

The World Health Organisation has suspended clinical trials of hydroxychloroquine as a potential COVID-19 treatment as a precautionary measure. WHO's decision follows the publishing of a study in the scientific journal The Lancet which stated that administering HCQ to COVID-19 patients could cause serious side-effects including heart arrhythmia increasing their chances of dying.